Publications by authors named "H Borzuta"
Article Synopsis
- The renin-angiotensin-aldosterone system (RAAS) is essential for regulating cardiovascular health and is a target for various therapeutic drugs, especially in managing diseases like hypertension and heart failure.
- Dysregulation of RAAS has drawn attention in cancer treatment due to its impact on tumor biology and cardiovascular toxicities from oncological therapies.
- RAAS inhibitors (RAASi) could serve as supportive treatments that help mitigate cardiovascular risks and improve outcomes in cancer patients undergoing therapies that can lead to cardiovascular complications.
Cancer is the leading cause of death worldwide, and the number of cancer-related deaths is expected to increase. Common types of cancer include skin, breast, lung, prostate, and colorectal cancers. While clinical research has improved cancer therapies, these treatments often come with significant side effects such as chronic fatigue, hair loss, and nausea.
View Article and Find Full Text PDFNeurodegenerative diseases, which occur when neurons begin to deteriorate, affect millions of people worldwide. These age-related disorders are becoming more common partly because the elderly population has increased in recent years. While no treatments are accessible, every year an increasing number of therapeutic and supportive options become available.
View Article and Find Full Text PDF